Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel

• Status: Terminated
• Trial end date: 0000-00-00
• Target enrollment: 7
• Participant gender: Both

Summary

RATIONALE: Acupuncture may help relieve nerve pain caused by chemotherapy.

PURPOSE: This randomized clinical trial is studying how well acupuncture works in treating nerve pain in patients with stage I, stage II, and stage III breast cancer who are receiving paclitaxel.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: City of Hope Medical Center
• Treatments: Albumin-Bound Paclitaxel; Paclitaxel
• Last Updated: 2012-07-13

Criteria

Inclusion

• Patients must have a history of histologically or cytologically confirmed stage I, II, or III breast cancer that have received 2 cycles of paclitaxel, and expected to receive paclitaxel for two more cycles, and are experiencing grade 1 peripheral neuropathy (CTCAE criteria)

• Performance ECOG 0-2 (Karnofsky Performance Status >= 60%)

• Life expectancy of greater than 6 months

• Ability to understand and the willingness to sign a written informed consent document

Exclusion

• Patients with radiologically confirmed stage IV breast cancer

• Patients who had acupuncture in the previous 8 weeks

• Change in use of any of the following drugs in the prior 4 weeks: opiates, antidepressants, or anxiolytics ("change" is defined as initiation or cessation of treatment, or change in prescribed dose or regimen)

• Patients with needle phobia

• Patients who experienced any peripheral neuropathy prior to chemotherapy

• Patients who have the potential for serious bleeding due to inherited diseases such as hemophilia

• Patients with diabetes